Ferguson Wellman Capital Management, Inc Edwards Lifesciences Corp Transaction History

Ferguson Wellman Capital Management, Inc

$4.79 Billion
Q2 2024

A detailed history of Ferguson Wellman Capital Management, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ferguson Wellman Capital Management, Inc holds 28,174 shares of EW stock, worth $1.84 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

28,174

Previous 28,324 0.53%

Holding current value

$1.84 Million

Previous $2.71 Million 3.84%

% of portfolio

0.05%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$84.3 - $94.31 $12,645 - $14,146	-150 Reduced 0.53%	28,174 $2.6 Million
Q1 2024 Apr 09, 2024	SELL	$72.54 - $95.56 $3,627 - $4,778	-50 Reduced 0.18%	28,324 $2.71 Million
Q3 2023 Oct 12, 2023	SELL	$69.28 - $93.38 $10,738 - $14,473	-155 Reduced 0.54%	28,374 $1.97 Million
Q2 2023 Jul 11, 2023	BUY	$81.41 - $94.33 $6,838 - $7,923	84 Added 0.3%	28,529 $2.69 Million
Q1 2023 Apr 20, 2023	SELL	$74.26 - $84.51 $4,529 - $5,155	-61 Reduced 0.21%	28,445 $2.35 Million
Q3 2022 Oct 17, 2022	SELL	$82.37 - $107.29 $33,689 - $43,881	-409 Reduced 1.41%	28,506 $2.36 Million
Q2 2022 Jul 14, 2022	SELL	$86.5 - $128.27 $5,276 - $7,824	-61 Reduced 0.21%	28,915 $2.75 Million
Q1 2022 Apr 14, 2022	BUY	$101.96 - $128.34 $8,360 - $10,523	82 Added 0.28%	28,976 $3.41 Million
Q4 2021 Jan 10, 2022	SELL	$106.37 - $130.68 $41,803 - $51,357	-393 Reduced 1.34%	28,894 $3.74 Million
Q2 2021 Jul 12, 2021	SELL	$83.84 - $104.76 $1,089 - $1,361	-13 Reduced 0.04%	29,287 $3.03 Million
Q4 2020 Feb 04, 2021	SELL	$71.69 - $91.23 $65,237 - $83,019	-910 Reduced 3.01%	29,300 $2.67 Million
Q2 2020 Aug 04, 2020	BUY	$57.54 - $76.95 $1.15 Million - $1.54 Million	20,048 Added 197.28%	30,210 $2.09 Million
Q4 2019 Jan 24, 2020	SELL	$71.7 - $82.09 $717 - $820	-10 Reduced 0.1%	10,162 $2.37 Million
Q2 2019 Jul 16, 2019	SELL	$55.74 - $64.41 $12,207 - $14,105	-219 Reduced 2.11%	10,172 $1.88 Million
Q3 2018 Oct 25, 2018	SELL	$45.7 - $58.03 $5,484 - $6,963	-120 Reduced 1.14%	10,391 $1.81 Million
Q2 2018 Aug 10, 2018	SELL	$42.45 - $51.3 $2,122 - $2,565	-50 Reduced 0.47%	10,511 $1.53 Million
Q1 2018 Apr 09, 2018	BUY	$37.19 - $47.45 $7,512 - $9,584	202 Added 1.95%	10,561 $1.47 Million
Q4 2017 Jan 24, 2018	BUY	$33.79 - $39.39 $4,899 - $5,711	145 Added 1.42%	10,359 $1.17 Million
Q3 2017 Oct 11, 2017	BUY	$36.29 - $38.83 $370,666 - $396,609	10,214	10,214 $1.12 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ferguson Wellman Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ferguson Wellman Capital Management, Inc with notifications on news.

Account

Ferguson Wellman Capital Management, Inc Edwards Lifesciences Corp Transaction History